UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II study SECOMBIT (sequential combo immuno and target therapy study): A subgroup analysis with a longer follow-up

JOURNAL OF CLINICAL ONCOLOGY, 2022, Vol.40 (16_suppl), p.9535-9535

2022

Volltextzugriff (PDF)

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study

Melanoma research, 2018-08, Vol.28 (4), p.333-340

2018

Volltextzugriff (PDF)

Erratum: Why vitamin D for cancer patients?

Ecancermedicalscience, 2021, Vol.15, p.1328-1328

2021

Volltextzugriff (PDF)

Angiogenesis in myelodysplastic syndromes

British Journal of Cancer, 1999-12, Vol.81 (8), p.1398-1401

1999

Volltextzugriff (PDF)

Brain metastases and survival evaluation in the SECOMBIT trial

ANNALS OF ONCOLOGY, 2023, Vol.34, p.S653

2023

Volltextzugriff (PDF)

Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation

ANNALS OF ONCOLOGY, 2022, Vol.33 (7), p.S1408

2022

Volltextzugriff (PDF)

Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers

Annals of oncology, 2001-07, Vol.12 (7), p.987-990

2001

Volltextzugriff (PDF)

Angiogenic growth factors and endostatin in non‐Hodgkin's lymphoma

British journal of haematology, 1999-08, Vol.106 (2), p.504-509

1999

Volltextzugriff (PDF)

SECOMBIT: The best sequential approach with combo immunotherapy [ipilimumab (I) /nivolumab (N)] and combo target therapy [encorafenib (E)/binimetinib (B)] in patients with BRAF mutated metastatic melanoma: A phase II randomized study

ANNALS OF ONCOLOGY, 2021, Vol.32, p.S1316

2021

Volltextzugriff (PDF)

The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells

Cell, 1993-08, Vol.74 (3), p.423-431

1993

Volltextzugriff (PDF)

Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia

Blood, 1995-04, Vol.85 (7), p.1871-1880

1995

Volltextzugriff (PDF)

First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted therapy study)

ANNALS OF ONCOLOGY, 2020, Vol.31, p.S1173

2020

Volltextzugriff (PDF)

Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation : analysis of overall and septic complications in 68 cases using a single type of device

Bone marrow transplantation (Basingstoke), 1999-07, Vol.24 (1), p.89-93

1999

Volltextzugriff (PDF)

Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARα fusion protein

Blood, 1998-10, Vol.92 (7), p.2244-2251

1998

Volltextzugriff (PDF)

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience

Ecancermedicalscience, 2016-03, Vol.10, p.624-624

2016

Volltextzugriff (PDF)

Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma

Blood, 2000-07, Vol.96 (1), p.282-287

2000

Volltextzugriff (PDF)

Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling

Molecular and Cellular Biology, 1997-08, Vol.17 (8), p.4859-4869

1997

Volltextzugriff (PDF)

Effects on differentiation by the promyelocytic leukemia PML/RAR alpha protein depend on the fusion of the PML protein dimerization and RAR alpha DNA binding domains

The EMBO journal, 1996-09, Vol.15 (18), p.4949-4958

1996

Volltextzugriff (PDF)

Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer

Clinical cancer research, 2004-09, Vol.10 (18), p.6039-6046

2004

Volltextzugriff (PDF)

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)

Journal for immunotherapy of cancer, 2013-11, Vol.1 (S1), p.P69-P69, Article P69

2013

Volltextzugriff (PDF)

Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival

Oncogene, 1998-06, Vol.16 (22), p.2905-2913

1998

Volltextzugriff (PDF)

Cell Death Induction by the Acute Promyelocytic Leukemia-Specific PML/RARα Fusion Protein

Proceedings of the National Academy of Sciences - PNAS, 1997-09, Vol.94 (20), p.10901-10906

1997

Volltextzugriff (PDF)

Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy

Bone marrow transplantation (Basingstoke), 2000, Vol.25 (2), p.173-177

2000

Volltextzugriff (PDF)

Efficacy of 90Y ibritumomab-tiuxetan treatment in a case of resistant gastric MALT non-Hodgkin's lymphoma

Ecancermedicalscience, 2008-03, Vol.2, p.79

2008

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(66)
Tagungsberichte
(5)

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(61)
Humans
(49)
Biological And Medical Sciences
(41)
Medical Sciences
(41)
Radiology, Nuclear Medicine & Medical Imaging
(37)
Adult
(22)
Male
(22)
Middle Aged
(22)
Female
(18)
Aged
(15)
Gastroenterology. Liver. Pancreas. Abdomen
(15)
Magnetic Resonance Imaging
(15)
Oncology
(15)
Liver Neoplasms - Diagnosis
(13)
Tumors
(12)
Animals
(10)
Liver - Pathology
(10)
Hematology
(9)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial

Phase II study SECOMBIT (sequential combo immuno and target therapy study): A subgroup analysis with a longer follow-up

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study

Erratum: Why vitamin D for cancer patients?

Angiogenesis in myelodysplastic syndromes

Brain metastases and survival evaluation in the SECOMBIT trial

Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation

Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers

Angiogenic growth factors and endostatin in non‐Hodgkin's lymphoma

SECOMBIT: The best sequential approach with combo immunotherapy [ipilimumab (I) /nivolumab (N)] and combo target therapy [encorafenib (E)/binimetinib (B)] in patients with BRAF mutated metastatic melanoma: A phase II randomized study

The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells

Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia

First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted therapy study)

Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation : analysis of overall and septic complications in 68 cases using a single type of device

Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARα fusion protein

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience

Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma

Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling

Effects on differentiation by the promyelocytic leukemia PML/RAR alpha protein depend on the fusion of the PML protein dimerization and RAR alpha DNA binding domains

Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)

Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival

Cell Death Induction by the Acute Promyelocytic Leukemia-Specific PML/RARα Fusion Protein

Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy

Efficacy of 90Y ibritumomab-tiuxetan treatment in a case of resistant gastric MALT non-Hodgkin's lymphoma

Suchergebnisse filtern